Hep C - GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial
Medical News Today - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

BioCryst Reports Fourth Quarter and Year-End 2005 Financial Results
dBusinessNews.com - Offering comprehensive Web design services to new economy enterprises across a wide range of platforms and technologies, Web Design Studio takes pride in delivering big-business Internet solutions to small and medium-sized businesses. BIRMINGHAM

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Hep C - Migenix: infectious ambitions in hepatitis

Migenix: infectious ambitions in hepatitis
Pharmaceutical Business Review - Jan 25 6:07 PM
Migenix has confirmed plans to initiate a viral kinetics study with celgosivir in hepatitis C.Save to My Web

Biologic shows promise in severe Crohn's disease
Medical Post Online - Feb 20 7:32 PM
The monoclonal antibody Remicade (infliximab) is now indicated for treatment of fistulizing Crohn's disease in adults who have responded inadequately to conventional treatment.Save to My Web

Idenix and Novartis Seek European Approval of Telbivudine for the Treatment of Patients with Chronic Hepatitis B
[Press Release] PR Newswire via Yahoo! Finance - Feb 07 5:00 AM
Idenix Pharmaceuticals, Inc. and Novartis announced today the submission of a Marketing Authorization Application to the European Medicines Agency seeking marketing authorization for the 600 mg dose of telbivudine for the treatment of chronic hepatitis B.Save to My Web

YOU ARE HERE:
Aidsmap - Jan 26 4:13 AM
Using liver biopsies the researchers established that 25% of patients with normal alanine aminotransferase (ALT) levels - a key marker of liver function have such severe liver damage that they require anti-hepatitis C treatment, with 13% having cirrhosis, permanent scarring of the liver.Save to My Web

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
vwd.de - Jan 31 9:18 AM
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.Save to My Web

Hep C - Hepatitis C

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc. ... A, non-B hepatitis. They called the new virus hepatitis C virus (HCV). Subsequently, the complete genomes of various HCV ...

What I Need to Know About Hepatitis C
Explains how the hepatitis virus affects the liver, how it is spread, symptoms of infection, and treatment options.

Ready to Learn: All About Hepatitis C
Ready to Learn: All About Hepatitis C Ready to Learn: All About Hepatitis C This comprehensive online resource for information about Hepatitis C is provided as a public service by Schering Corporation, the medical research and development ...

National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection. The coalition is an affiliation of organizations and individuals committed to raising awareness, ... and support to prisoners infected with hepatitis C and HIV/HCV coinfection ...

HepCnet, Hepatitis C information support and resources, Hep C support
Hepatitis C virus information and support for people suffering from Hepatitis C. We are here to support and offer compassion that can only come from the personal experiences of hundreds of other Hepatitis C victims

Hep C - Waging War on Hepatitis C

Waging War on Hepatitis C
Blink: Hepatitis C Added by mfeed BusinessWeek - Many viruses have figured out ways to elude the body's protective system. One of the cleverest is the hepatitis-C virus. In scores of millions of infected people, the bug does its damage by making trillions of new viruses a day, years after year. The ...... Read more... Discover what is wrong with Medical Insurance

Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and ...
Blink: Hepatitis C Added by mfeed Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques ...... Read more... Discover what is wrong with Medical Insurance

Hep C - euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
Presseportal - Jan 31 9:08 AM
31.01.2006 Intercell (VSE; "ICLL") today announced initial data from a clinical trial aiming at the optimization of its therapeutic Hepatitis C vaccine IC41. Results ...Save to My Web

YOU ARE HERE:
Aidsmap - Jan 23 4:58 PM
Fatigue is more than twice as prevalent as depression during anti-hepatitis C (HCV) treatment in HIV-positive individuals, according to a study presented to the Second International Workshop on HIV and Hepatitis Coinfection, held in Amsterdam earlier this month.Save to My Web

Health Business
UPI - Jan 23 1:33 PM
VANCOUVER, British Columbia, Jan. 23 (UPI) -- Migenix said Monday it would launch early in the second quarter of 2006 a trial of hepatitis C drug MX-3253.Save to My Web

YOU ARE HERE:
Aidsmap - Feb 17 4:58 AM
Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two studies presented last week at the Thirteenth Conference on Retroviruses and Opportunistic Infections in Denver.Save to My Web

Peregrine advances hepatitis C drug
Pharmaceutical Business Review - Feb 16 6:24 PM
Peregrine Pharmaceuticals, a biopharmaceutical company focusing on viral diseases and cancer, has completed planned patient enrollment and dosing in its initial phase I clinical trial for Tarvacin anti-viral in the treatment of chronic hepatitis C virus infection.Save to My Web

Hep C - Health Tip: Nail Salon Safety

Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Hep C - BioCryst Reports Fourth Quarter and Year-End 2005 Financial Results

BioCryst Reports Fourth Quarter and Year-End 2005 Financial Results
dBusinessNews.com - Offering comprehensive Web design services to new economy enterprises across a wide range of platforms and technologies, Web Design Studio takes pride in delivering big-business Internet solutions to small and medium-sized businesses. BIRMINGHAM

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial
Medical News Today - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated

Hep C - Hepatitis C

Hepatitis C
... Documented evidence of chronic Hepatitis C. Length/Duration: Treatment duration may be up to 48 weeks ... at least 18 years old with chronic hepatitis C. Latino or Non-Latino Caucasion ...

A.R.E. Health & Rejuvenation Research Center - The Cayce Health Database
... Diseases, National Institutes of Health) Chronic hepatitis C varies greatly in its course and outcome ... 20 percent of patients with chronic hepatitis C develop cirrhosis, a process ...

Hepatitis
... incidence of sexual transmission from a patient with chronic hepatitis C infection seems to be quite low, in ... times a week to treat chronic hepatitis C, peginterferon alpha needs to ...

Chronic Hepatitis C
65th Annual Scientific Meeting of the American College of Gastroenterology ... Chronic hepatitis C represents a significant public health challenge in the United States ... The peak prevalence of chronic hepatitis C is in the fourth and fifth decades of life, with ...

Chronic Hepatitis C
Digestive diseases terms and information. ... Chronic Hepatitis C. The hepatitis C virus (HCV) is one of the most important causes of ... information from government publications about chronic hepatitis C that have been reformatted ...

Symptoms of Chronic HepC
... In fact, chronic hepatitis C can be present for as long as 20 years without presenting any obvious ... symptoms experienced by people with chronic hepatitis C. At first glance, the ...

Hep C - Pearson: UCSU to BCAP

Pearson: UCSU to BCAP
Colorado Daily - Feb 18 11:20 PM
At a casual glance, recent CU-Boulder graduate Eugene Pearson shouldn't have had a hard time finding a job.Save to My Web

Tainted blood case may be in jeopardy
Miami Herald - Feb 14 6:10 PM
The case against four physicians and a U.S. pharmaceutical company accused of failing to properly screen blood that infected thousands of Canadians with HIV and hepatitis was in jeopardy Monday after a key witness cast doubt on some evidence.Save to My Web

Starting small, dreaming big
Tallahassee Democrat - Feb 18 2:34 AM
Seeds of research start small, and in unexpected places. In the case of Hengli Tang, a biology professor at Florida State University, they begin with a boy in the Anhui province of China near Shanghai. Tang's high-school biology teacher tells him biology will be the science of the 21st century.Save to My Web

Intervention urged for hepatitis C victims
New Kerala - Feb 06 10:02 PM
NEW YORK: Scientists from across the nation are urging an immediate public health intervention to treat young injection drug users infected with hepatitis C.Save to My Web

Hep C - HCV Forum with Dr. Ben Cecil

HCV Forum with Dr. Ben Cecil
Welcome to the HCV forum. I have been interested in treating patients with HCV for five years and have treated more than 1800 patients with antiviral ...

Hepatitis C
[Prior to the discovery of HCV, hepatitis following blood transfusion that ... Sexual transmission between monogamous couples is rare but HCV infection is ...

Hawaii Center for Volcanology
Information and research on Hawaiian Volcanoes by the University of Hawaii.

National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

Hep C - Hepatitis C Association, Hepatitis C awareness, donor support, and

Hepatitis C Association, Hepatitis C awareness, donor support, and
Includes details about the organization, events, news, brochures, related links and contact information.

Hepatitis C
The main reason for the drastic increase in severe hepatitis C-related liver disease--that means leading to transplant, leading to death--is that 90 percent of people with chronic

Disease tests
About 2% have been infected with hepatitis C. Infectious diseases could be detected by analyzing blood and urine. Devices like cassettes and strips are used to detect the presence of infection

Pegasys.com: Do You Have Hepatitis C?
Pegasys.com features hepatitis C risk factors, diagnosis, support, and treatment with PEGASYS (peginterferon alfa-2a), a pegylated alpha interferon, for patients, family, friends, caregivers, and

Welcome Page
Details about this nonprofit organization which is dedicated to raising awareness of, and assisting people affected by Hepatitis C. Includes news and Q&As about the disease and contact information.

Hep C - Peregrine Announces Completion of Planned Patient Enrollment and ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
Yahoo! News (press release) - Feb 15, 2006TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), a biopharmaceutical company ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
Biotech Intelligence (press release), France - Jan 18, 2006TUSTIN, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a biopharmaceutical company with ...

Peregrine Announces Completion of Planned Patient Enrollment and ...
PR Newswire (press release), NY - Feb 15, 2006- HCV Clinical Expert Dr. John McHutchison Also Joins Peregrine SRB - TUSTIN, Calif., Feb. 15 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. ...

Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral ...
PR Newswire (press release), NY - Jan 18, 2006- Patient Enrollment and Dosing in Initial Phase I Trial Now Scheduled for Completion in February - - Preliminary Phase I Safety Data to Be Presented at 'Viral ...